Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022

Rhea-AI Summary

Horizon Therapeutics plc (Nasdaq: HZNP) will release its Q2 2022 financial results on August 3, 2022, at 8 a.m. Eastern Time. A live webcast will follow, allowing management to present an overview of the company's financial and operational performance. Investors are encouraged to join the webcast via Horizon's investor relations website, with a replay available two hours post-event. Horizon is focused on developing and commercializing medicines for rare and autoimmune diseases, highlighting their commitment to impactful therapies.

Positive

• Scheduled Q2 2022 earnings release indicates ongoing business activity.

Negative

• None.

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its second-quarter 2022 financial results on Wednesday, Aug. 3, 2022. Following the announcement, Horizon’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.

The live webcast may be accessed at http://ir.horizontherapeutics.com. Please connect to the Company’s website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. A replay will be available approximately two hours after the live webcast.

About Horizon

Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220707005131/en/

Investor Relations:

Tina Ventura

Senior Vice President, Chief Investor Relations Officer

Investor-relations@horizontherapeutics.com

U.S. Media:

Geoff Curtis

Executive Vice President, Corporate Affairs & Chief Communication Officer

media@horizontherapeutics.com

Ireland Media:

Gordon MRM

Ray Gordon

ray@gordonmrm.ie

Source: Horizon Therapeutics plc

FAQ

When will Horizon Therapeutics announce its Q2 2022 earnings?

Horizon Therapeutics will announce its Q2 2022 earnings on August 3, 2022.

What time is the Horizon Therapeutics Q2 2022 earnings call?

The earnings call will start at 8 a.m. Eastern Time on August 3, 2022.

How can I access the Horizon Therapeutics Q2 2022 earnings webcast?

The Q2 2022 earnings webcast can be accessed at Horizon's investor relations website.

What types of diseases does Horizon Therapeutics focus on?

Horizon Therapeutics focuses on rare, autoimmune, and severe inflammatory diseases.

Where can I find more information about Horizon Therapeutics?

More information about Horizon Therapeutics can be found on their official website.